SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Corcoran, C.
Right arrow Articles by O’Keane, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corcoran, C.
Right arrow Articles by O’Keane, V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Bupropion in the management of apathy

C. Corcoran

Department of Psychiatry, Beaumont Hospital, Dublin, Ireland. corcoranciaran{at}oz.ie

M. L. Wong

Department of Psychiatry, Beaumont Hospital, Dublin, Ireland.

V. O’Keane

Department of Perinatal Psychiatry, Institute of Psychiatry, King’s College London, De Crespigny Park, London, UK.

We report on three males with prominent apathy as part of the symptom complex of depression or organic brain disease. Significant clinical responses were observed following treatment with bupropion, an antidepressant with dopamine (DA) reuptake activity. We present clinical evidence in support of the hypothesis that remission in these patients occurred as a consequence of bupropion-induced increases in central DA neurotransmission.

Key Words: apathy • bupropion • dopamine

Journal of Psychopharmacology, Vol. 18, No. 1, 133-135 (2004)
DOI: 10.1177/0269881104043284
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
S E Starkstein and A F G Leentjens
The nosological position of apathy in clinical practice
J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1088 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
K. Demyttenaere and L. Jaspers
Review: Bupropion and SSRI-induced side effects
J Psychopharmacol, September 1, 2008; 22(7): 792 - 804.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
D. Nutt, K. Demyttenaere, Z. Janka, T. Aarre, M. Bourin, P. L. Canonico, J. L. Carrasco, and S. Stahl
The other face of depression, reduced positive affect: the role of catecholamines in causation and cure
J Psychopharmacol, July 1, 2007; 21(5): 461 - 471.
[Abstract] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
P. R. Padala, W. J. Burke, S. C. Bhatia, and F. Petty
Treatment of Apathy With Methylphenidate
J Neuropsychiatry Clin Neurosci, February 1, 2007; 19(1): 81 - 83.
[Abstract] [Full Text] [PDF]


Advertisement